Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina. (2021)

First Author: Chandler LC
Attributed to:  Development of AAV gene therapy for blindness caused by cone-rod dystrophy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.omtm.2021.05.011

PubMed Identifier: 34485594

Publication URI: http://europepmc.org/abstract/MED/34485594

Type: Journal Article/Review

Volume: 22

Parent Publication: Molecular therapy. Methods & clinical development

ISSN: 2329-0501